Characterisation of Patients with Severe Asthma in Primary and Secondary Care Settings in Europe reported to be eligible for biological therapy

Trial Identifier: D3250R00039
Sponsor: AstraZeneca
NCTID:: NCT03629782
Start Date: April 2018
Primary Completion Date: July 2020
Study Completion Date: July 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Bulgaria Pleven, Bulgaria, 5800
Czech Republic Havirov, Czech Republic, 73506
France, Hauts de France Cappelle en Pevele, Hauts de France, France, 59242
Germany Reinfeld, Germany, 23858
Greece, Aigaleo Athens, Aigaleo, Greece, 12242
Hungary Budapest, Hungary, 1135
Italy, Sassari Sardinia, Sassari, Italy, 7100
Netherlands Groningen, Netherlands, 9745 DH
Poland Wieruszow, Poland, 98400
Romania Bacau, Romania, 600114
Slovenia Slovenj Gradec, Slovenia, 2380
Spain, Andalusia Malaga, Andalusia, Spain, 29004